Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Pathol Int. 2010 Jan;60(1):1-8. doi: 10.1111/j.1440-1827.2009.02477.x.
The classification and grading of papillary urothelial neoplasms has been a long-standing subject of controversy. Previously, numerous diverse grading schemes for bladder tumor, including the 1973 World Health Organization (WHO) classification, existed whereby one of the major limitations was poor inter-observer reproducibility among pathologists. The WHO/International Society of Urological Pathology (ISUP) consensus classification system of urothelial neoplasms of the urinary bladder was developed in 1998 and was revised most recently in 2003 (published in 2004). Importantly, the current classification system provides detailed histological criteria for papillary urothelial lesions and allows for designation of a lesion (papillary urothelial neoplasm of low malignant potential) with a negligible risk of progression. Thus, the latest system is designed to be a universally acceptable one for bladder tumors that not only could be effectively used by pathologists, urologists, and oncologists, but also stratifies the tumors into prognostically significant categories. This article outlines the 2004 WHO/ISUP classification system regarding the specific histological criteria for non-invasive papillary urothelial neoplasms and the clinical significance of each category.
乳头状尿路上皮肿瘤的分类和分级一直是一个备受争议的话题。此前,存在许多不同的膀胱肿瘤分级方案,包括 1973 年世界卫生组织(WHO)的分类,其中一个主要的局限性是病理学家之间的观察者间重复性差。1998 年制定了世界卫生组织/国际泌尿病理学会(ISUP)共识的膀胱尿路上皮肿瘤分类系统,并于 2003 年进行了最近一次修订(2004 年出版)。重要的是,目前的分类系统为乳头状尿路上皮病变提供了详细的组织学标准,并允许指定具有低进展风险的病变(低度恶性潜能的乳头状尿路上皮肿瘤)。因此,最新的系统旨在成为一种普遍接受的膀胱肿瘤分类系统,不仅可以被病理学家、泌尿科医生和肿瘤学家有效使用,而且还可以将肿瘤分为具有预后意义的类别。本文概述了 2004 年 WHO/ISUP 分类系统关于非浸润性乳头状尿路上皮肿瘤的具体组织学标准和每个类别的临床意义。
Hum Pathol. 2012-4-26
Asian J Urol. 2024-10
Children (Basel). 2023-9-25
Int J Mol Sci. 2023-3-27